1-20 of 554
Sort by
News

RedirecTT-1 Combo of Teclistamab and Talquetamab Suggests Efficacy in R/R MM

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, RedirecTT-1 Combo of Teclistamab and Talquetamab Suggests Efficacy in R/R MM
News

GPRC5D-Directed CAR T-Cell Therapy BMS-986393 Shows Potential for R/R MM

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, GPRC5D-Directed CAR T-Cell Therapy BMS-986393 Shows Potential for R/R MM
News

MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation
News

Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP
News

Rusfertide Effectively Supports Hematocrit Control in PV

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Rusfertide Effectively Supports Hematocrit Control in PV
News

Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
News

MajesTEC-2: Future of BCMA-targeted Bispecific, Gamma Secretase Inhibitor Combo in Question

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, MajesTEC-2: Future of BCMA-targeted Bispecific, Gamma Secretase Inhibitor Combo in Question
News

Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B
News

Mediastinal Radiotherapy Safe To Omit in PMBCL After Complete Metabolic Response

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Mediastinal Radiotherapy Safe To Omit in PMBCL After Complete Metabolic Response
News

Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP
News

Intrathecal and Intravenous Methotrexate Prophylaxis Show Similar Efficacy for CNS Relapse in High-Risk DLBCL

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Intrathecal and Intravenous Methotrexate Prophylaxis Show Similar Efficacy for CNS Relapse in High-Risk DLBCL
News

Combination Therapy for Richter Syndrome Explored

Ruth Jessen Hickman, MD
Published: 2023
Abstract
Mid-July 2023
View News titled, Combination Therapy for Richter Syndrome Explored
News

Epcoritamab Plus Lenalidomide and Rituximab Yields High Response in R/R FL

Katie Robinson
Published: 2023
Abstract
Mid-July 2023
View News titled, Epcoritamab Plus Lenalidomide and Rituximab Yields High Response in R/R FL
News

Study Addresses Oncology Clinician Burnout at a Community Cancer Center

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Study Addresses Oncology Clinician Burnout at a Community Cancer Center
News

Luspatercept Effective for the Treatment of Anemia in Patients with Myelofibrosis

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Luspatercept Effective for the Treatment of Anemia in Patients with Myelofibrosis
News

CHOP with Anti-CCR4 Antibody Effective for Older Patients with T-Cell Leukemia/Lymphoma

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, CHOP with Anti-CCR4 Antibody Effective for Older Patients with T-Cell Leukemia/Lymphoma
News

Liso-Cel Yields Durable Response in R/R CLL/SLL

Katie Robinson
Published: 2023
Abstract
Mid-July 2023
View News titled, Liso-Cel Yields Durable Response in R/R CLL/SLL
News

Phase II Linvoseltamab Study Confirms Efficacy in R/R MM

Katie Robinson
Published: 2023
Abstract
Mid-July 2023
View News titled, Phase II Linvoseltamab Study Confirms Efficacy in R/R MM
News

Nivolumab Improves PFS Over Brentuximab Vedotin in Advanced-Stage cHL

Katie Robinson
Published: 2023
Abstract
Mid-July 2023
View News titled, Nivolumab Improves PFS Over Brentuximab Vedotin in Advanced-Stage cHL
News

Results from Combination Trial in Older Adults with Treatment-Naïve CLL Confounded by COVID-Related Deaths

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Results from Combination Trial in Older Adults with Treatment-Naïve CLL Confounded by COVID-Related Deaths